Effectiveness of Preoperative Antiseptic Preparation in Transnasal Skull Base Surgery: A Randomized Three-Arm Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 142
- 试验地点
- 2
- 主要终点
- the difference in the incidence of postoperative infections within 30 days of surgery between the three interventional groups
研究概览
简要总结
Objective: Transnasal skull-base surgery is a complex and invasive procedure that involves the use of preoperative antiseptic preparations. However, evidence supporting their use in preventing postoperative infectious complications is limited. The aim of this study is to assess the efficacy of preoperative antiseptic techniques in reducing postoperative infectious complications within 30 days of surgery.
Methods: A multicenter, prospective, randomized, single-blind, three-arm trial was conducted from February 2019 to October 2021. Participants were randomized to either of three antiseptic preparation techniques: external 0.9%NaCl nasal preparation, external 0.05% chlorhexidine gluconate, or intranasal irrigation with 80 mg of gentamicin added to 1000 ml of 0.9%NaCl plus external nasal preparation with chlorhexidine gluconate 0.05%. A total of 130 adults with skull-base pathologies were randomized, 12 were excluded before randomization for failure to meet inclusion criteria (n=9) or refusal to participate (n=3). The investigators excluded patients with evidence of infection adjacent to the surgical site, allergies to preparation methods, those who underwent craniotomy during the same admission, and pediatric patients.
详细描述
Study Design This is a multicenter, prospective, randomized, single-blind, three-arm trial conducted at three skull base centers in Riyadh, Saudi Arabia. The null hypothesis was that infectious outcomes would not differ between the three intervention groups.
Ethics Consideration The patients provided written informed consent to participate, and the institutional review boards approved the study of the participating institutions. This study was approved by the Ethics Review Boards (E-18-3331). This study was conducted using the CONSORT guidelines.7
Population Patients were screened at neurosurgery service in three skull base centers from February 2019 to September 2021; follow-up was completed in October 2021. Eligible patients were adults with skull base pathologies scheduled for ETSBS. The exclusion criteria included pediatric patients aged <14 years, known allergy to CHG or gentamicin, evidence of infection at or adjacent to the operative site prior to surgery, open craniotomy during hospitalization, and immunosuppression. Fourteen years of age was used as the age limit as this is the age of the pediatric population in the Saudi health system.
Interventional Groups Three antiseptic preparation techniques were utilized in this study in a stepwise fashion, from minimal to maximal antisepsis: Group 1, external 0.9% NaCl nasal preparation; Group 2, external nasal preparation with antisepsis by CHG 0.05%; and Group 3, intranasal irrigation with 80 mg of gentamicin added to 1000 ml of 0.9% NaCl plus external nasal preparation with antisepsis by CHG 0.05%
Randomization Procedure Patients were randomized into blocks of three intervention groups and distributed to the participating centers. The primary surgeon was blinded to the intervention method until the day of surgery. The patients were randomized using a computer-generated list of random numbers (http://www.randomizer.org). Block randomization in three-patient blocks based on the institution was performed to ensure that approximately equal numbers of patients in each group from each site were randomized.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 14 Years 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults with skull base pathologies scheduled for ETSBS
排除标准
- •Pediatric patients aged <14 years
- •Known allergy to CHG or gentamicin
- •Evidence of infection at or adjacent to the operative site prior to surgery
- •Open craniotomy during hospitalization
- •Immunosuppression
结局指标
主要结局
the difference in the incidence of postoperative infections within 30 days of surgery between the three interventional groups
时间窗: 30 days
次要结局
未报告次要终点
研究者
Sarah Basindwah
Neurosurgery resident
King Saud University
